Breaking News Instant updates and real-time market news.

TSLA

Tesla

$342.44

0.47 (0.14%)

, JPM

JPMorgan

$118.13

1.03 (0.88%)

12:30
08/07/18
08/07
12:30
08/07/18
12:30

Saudi sovereign wealth fund builds 3%-5% stake in Tesla, FT reports

Saudi Arabia's Public Investment Fund has built a stake of 3%-5% in Tesla (TSLA), The Financial Times reports, citing people with direct knowledge of the matter. The stake, which is below the 5% threshold that requires public disclosure, is worth $1.7B-$2.9B at Tesla's current share price and makes PIF one of Tesla's eight biggest shareholders. The sovereign wealth fund initially approached Tesla and its CEO Elon Musk to express interest in buying newly issued shares in the company, but one source says Tesla "did not act on the interest" and the PIF bought the shares in secondary markets with the help of JPMorgan (JPM).

TSLA

Tesla

$342.44

0.47 (0.14%)

JPM

JPMorgan

$118.13

1.03 (0.88%)

  • 07

    Aug

  • 07

    Aug

  • 12

    Oct

  • 29

    Oct

TSLA Tesla
$342.44

0.47 (0.14%)

08/03/18
08/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Hold at Canaccord. 2. Universal Forest (UFPI) initiated with a Buy at Seaport Global. 3. Zafgen (ZFGN) initiated with an Outperform at Wedbush. 4. Entera Bio (ENTX) initiated with a Buy at Maxim. 5. Huya initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/18
08/03/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ALLERGAN UPGRADED TO BUY: Mizuho analyst Irina Koffler upgraded Allergan (AGN) to Buy from Neutral and raised her price target for the shares to $210 from $194. The analyst views Allergan's risk/reward more favorably following the company's "strong" beat and raise quarter and the delayed introduction of Restasis generics. Allergan is up 1.2% in late morning trading. NEEDHAM UPS TRIPADVISOR TO HOLD: Needham analyst Laura Martin upgraded TripAdvisor (TRIP) to Hold from Underperform, saying that while the company's pivot to competing as an online travel agent has failed, its focus to grow its non-hotel businesses is a "higher ROI idea". FLOOR & DECOR DOWNGRADED AT JPMORGAN, PIPER: JPMorgan analyst Christopher Horvers downgraded Floor & Decor (FND) to Neutral from Overweight and lowered his price target for the shares to $45 from $59. The "story shift" taking place is likely to keep the shares in "purgatory," Horvers said following the company's Q2 results. Piper Jaffray analyst Peter Keith also downgraded Floor & Decor to Neutral and lowered his price target for the shares to $39 from $58. The analyst admitted his June upgrade of the stock was wrong following Floor & Decor's Q2 miss and guide down. Floor & Decor is down 6.4% in late morning trading. LUNA CUT TO MARKET PERFORM AT NORTHLAND: Northland analyst Tim Savageaux downgraded Luna Innovations (LUNA) to Market Perform from Outperform as he sees the shares reflecting the value of the "well executed" sale of the Opto Solutions unit at current levels. CANACCORD INITIATES TESLA WITH A HOLD: Canaccord analyst Jed Dorsheimer initiated Tesla (TSLA) with a Hold rating as he sees several risks around the company's financing, cash burn, and general maturity in the industry. Catalysts that could de-risk the shares include shifts in corporate governance, consistent production, and "a CEO who is not working 120 hours per week to hold things together," said Dorsheimer, who set a $336 price target on Tesla shares. BWS SAYS ARLO IPO ESTABLISHES VALUATION CASE FOR NETGEAR: BWS Financial analyst Hamed Khorsand said the pricing of Arlo Technologies' (ARLO) IPO establishes a valuation case for Netgear (NTGR). The analyst believes the IPO pricing gives some context to what Netgear's stake is worth and affirms his sum-of-parts reasoning for owning Netgear shares. He kept a Buy rating on the stock with a $64.50 price target.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
08/07/18
MSCO
08/07/18
NO CHANGE
Target $291
MSCO
Equal Weight
Morgan Stanley questions if time to 'fade the bounce' in Tesla
Morgan Stanley analyst Adam Jonas raised his Q3 Model 3 delivery volume forecast to the low end of Tesla's guidance, up from 33,600 to 50,400, which he notes represents a 50% hike. For 2019, he raised his Model 3 delivery forecast to 312,000 from 260,000 as he now assumes 6,000 per week for the year. However, he thinks the stock may struggle to sustain the "sharply higher" expectations following Tesla's stronger than expected Q2 report. Despite his adjustments, Jonas left his price target unchanged at $291 and reiterates his Equal Weight rating in a note to investors titled "Expectations High Again: Time to Fade the Bounce?"
JPM JPMorgan
$118.13

1.03 (0.88%)

07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $118
BMOC
Market Perform
JPMorgan price target raised to $118 from $110 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $118 and kept his Market Perform rating after its Q2 results, saying the earnings beat consensus on higher than expected capital markets-related revenues. The analyst notes that equities trading was especially strong, while provisions for loan losses at JPMorgan were also lower than previously modeled.
07/19/18
DZBN
07/19/18
UPGRADE
DZBN
Buy
JPMorgan upgraded to Buy from Hold at DZ Bank
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).

TODAY'S FREE FLY STORIES

IO

ION Geophysical

$16.65

0.05 (0.30%)

15:58
08/20/18
08/20
15:58
08/20/18
15:58
Hot Stocks
Breaking Hot Stocks news story on ION Geophysical »

Rajay Bagaria reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTX

Centex

$25.26

1.92 (8.23%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Centex 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story  

Qwest trading resumes

PAY

Verifone

$23.04

(0.00%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Verifone 

Verifone trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTU

Chad Therapeutics, Inc.

$25.26

1.925 (8.25%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Chad Therapeutics, Inc. 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$44.80

-0.44 (-0.97%)

, EIX

Edison International

$69.24

-0.62 (-0.89%)

15:56
08/20/18
08/20
15:56
08/20/18
15:56
Periodicals
California plan could let PG&E issue bonds to cover fire damages, Bloomberg says »

California Senator Bill…

PCG

PG&E

$44.80

-0.44 (-0.97%)

EIX

Edison International

$69.24

-0.62 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPY

Brookfield Property

$19.90

-0.19 (-0.95%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Options
Brookfield Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

VERI

Veritone

$11.25

-0.16 (-1.40%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Conference/Events
Veritone to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

CBS

CBS

$53.67

0.45 (0.85%)

15:46
08/20/18
08/20
15:46
08/20/18
15:46
Periodicals
Court revives copyright suit against CBS over pre-1972 recordings, Reuters says »

CBS is facing a lawsuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

TSLA

Tesla

$304.35

-0.98 (-0.32%)

15:42
08/20/18
08/20
15:42
08/20/18
15:42
Periodicals
Some Tesla suppliers worry about getting paid, WSJ reports »

Some Tesla suppliers have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

FIT

Fitbit

$6.02

0.315 (5.52%)

15:37
08/20/18
08/20
15:37
08/20/18
15:37
Hot Stocks
Fitbit announces Fitbit Charge 3 »

Earlier today, Fitbit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

NDSN

Nordson

$134.72

-0.07 (-0.05%)

15:34
08/20/18
08/20
15:34
08/20/18
15:34
Options
Nordson options imply 7.8% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

, GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

15:31
08/20/18
08/20
15:31
08/20/18
15:31
Periodicals
Google, IMAX VR project quietly canceled, Variety reports »

A joint virtual reality…

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

IMAX

Imax

$22.80

0.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 06

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

STAA

STAAR Surgical

$42.05

1.1 (2.69%)

15:24
08/20/18
08/20
15:24
08/20/18
15:24
Conference/Events
STAAR Surgical management to meet with William Blair »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

SRI

Stoneridge

$32.61

0.39 (1.21%)

15:23
08/20/18
08/20
15:23
08/20/18
15:23
Hot Stocks
Stoneridge appoints Laurent Borne as Chief Technology Officer »

Stoneridge announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

  • 06

    Nov

DVA

DaVita

$72.44

-0.05 (-0.07%)

15:22
08/20/18
08/20
15:22
08/20/18
15:22
Conference/Events
DaVita management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ALTR

Altair

$40.63

0.4 (0.99%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Conference/Events
Altair management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 12

    Sep

CBOE

Cboe Global Markets

$98.72

2.96 (3.09%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Options
Sweep buyer of CBOE calls »

Sweep buyer of CBOE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANH

Fanhua

$25.76

0.53 (2.10%)

15:19
08/20/18
08/20
15:19
08/20/18
15:19
Options
Fanhua options imply 7.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/20/18
08/20
15:17
08/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/20/18
08/20
15:16
08/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$38.84

0.17 (0.44%)

15:12
08/20/18
08/20
15:12
08/20/18
15:12
Conference/Events
Dentsply Sirona management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Sep

  • 06

    Nov

STZ

Constellation Brands, also tag STZ.B

$202.74

-1.16 (-0.57%)

15:11
08/20/18
08/20
15:11
08/20/18
15:11
Options
Repeat call spreads in Constellation Brands »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

LCI

Lannett

$5.43

-8.075 (-59.81%)

, AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

15:08
08/20/18
08/20
15:08
08/20/18
15:08
Recommendations
Lannett, Amneal Pharmaceuticals analyst commentary  »

Lannett price target…

LCI

Lannett

$5.43

-8.075 (-59.81%)

AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

  • 05

    Sep

  • 12

    Sep

15:05
08/20/18
08/20
15:05
08/20/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.